company background image
XTNT logo

Xtant Medical Holdings NYSEAM:XTNT Stock Report

Last Price

US$0.40

Market Cap

US$50.0m

7D

15.0%

1Y

-67.0%

Updated

23 Dec, 2024

Data

Company Financials +

Xtant Medical Holdings, Inc.

NYSEAM:XTNT Stock Report

Market Cap: US$50.0m

XTNT Stock Overview

Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. More details

XTNT fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Xtant Medical Holdings, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Xtant Medical Holdings
Historical stock prices
Current Share PriceUS$0.40
52 Week HighUS$1.31
52 Week LowUS$0.33
Beta0.35
1 Month Change2.00%
3 Month Change-40.33%
1 Year Change-66.97%
3 Year Change-36.02%
5 Year Change-74.85%
Change since IPO-99.90%

Recent News & Updates

Recent updates

Shareholders Are Thrilled That The Xtant Medical Holdings (NYSEMKT:XTNT) Share Price Increased 186%

Mar 02
Shareholders Are Thrilled That The Xtant Medical Holdings (NYSEMKT:XTNT) Share Price Increased 186%

Shareholder Returns

XTNTUS Medical EquipmentUS Market
7D15.0%-1.1%-2.2%
1Y-67.0%10.1%23.9%

Return vs Industry: XTNT underperformed the US Medical Equipment industry which returned 10% over the past year.

Return vs Market: XTNT underperformed the US Market which returned 23.4% over the past year.

Price Volatility

Is XTNT's price volatile compared to industry and market?
XTNT volatility
XTNT Average Weekly Movement7.4%
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.3%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: XTNT has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: XTNT's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a211Sean Brownewww.xtantmedical.com

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications.

Xtant Medical Holdings, Inc. Fundamentals Summary

How do Xtant Medical Holdings's earnings and revenue compare to its market cap?
XTNT fundamental statistics
Market capUS$50.04m
Earnings (TTM)-US$17.59m
Revenue (TTM)US$113.86m

0.5x

P/S Ratio

-3.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
XTNT income statement (TTM)
RevenueUS$113.86m
Cost of RevenueUS$44.53m
Gross ProfitUS$69.33m
Other ExpensesUS$86.92m
Earnings-US$17.59m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.13
Gross Margin60.89%
Net Profit Margin-15.45%
Debt/Equity Ratio76.1%

How did XTNT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:32
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Xtant Medical Holdings, Inc. is covered by 13 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason WittesAegis Capital Corporation
Jason WittesBrean Capital
Michael GormanBTIG